123 related articles for article (PubMed ID: 1416903)
1. Immunotoxic potential of antiviral drugs: effects of ganciclovir and (S)-1-(3-hydroxy-2-phosphonylmethoxy propyl) cytosine on lymphocyte transformation and delayed-type hypersensitivity responses.
Simecka JW; Patel P; Kern ER
Antiviral Res; 1992 May; 18(1):53-64. PubMed ID: 1416903
[TBL] [Abstract][Full Text] [Related]
2. Selective inhibition of human cytomegalovirus DNA synthesis by (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine [(S)-HPMPC] and 9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG).
Neyts J; Snoeck R; Schols D; Balzarini J; De Clercq E
Virology; 1990 Nov; 179(1):41-50. PubMed ID: 2171213
[TBL] [Abstract][Full Text] [Related]
3. Particular characteristics of the anti-human cytomegalovirus activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) in vitro.
Neyts J; Snoeck R; Balzarini J; De Clercq E
Antiviral Res; 1991 Jul; 16(1):41-52. PubMed ID: 1663729
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antiviral activity of the nucleotide analogue (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine.
Bronson JJ; Ghazzouli I; Hitchcock MJ; Webb RR; Martin JC
J Med Chem; 1989 Jul; 32(7):1457-63. PubMed ID: 2544723
[TBL] [Abstract][Full Text] [Related]
5. Comparative activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine against rat cytomegalovirus infection in vitro and in vivo.
Stals FS; de Clercq E; Bruggeman CA
Antimicrob Agents Chemother; 1991 Nov; 35(11):2262-6. PubMed ID: 1666493
[TBL] [Abstract][Full Text] [Related]
6. A method for detection of HHV-6 antigens and its use for evaluating antiviral drugs.
Yoshida M; Yamada M; Chatterjee S; Lakeman F; Nii S; Whitley RJ
J Virol Methods; 1996 Apr; 58(1-2):137-43. PubMed ID: 8783159
[TBL] [Abstract][Full Text] [Related]
7. Prolonged and potent therapeutic and prophylactic effects of (S)-1-[(3-hydroxy-2-phosphonylmethoxy)propyl]cytosine against herpes simplex virus type 2 infections in mice.
Yang H; Datema R
Antimicrob Agents Chemother; 1991 Aug; 35(8):1596-600. PubMed ID: 1929331
[TBL] [Abstract][Full Text] [Related]
8. A rapid protein A binding radioimmunoassay for the evaluation of antiviral agents.
Gangopadhyay NN; Whitley RJ; Chatterjee S
J Virol Methods; 1994 Jul; 48(2-3):273-9. PubMed ID: 7527404
[TBL] [Abstract][Full Text] [Related]
9. Antiviral activities of nucleosides and nucleotides against wild-type and drug-resistant strains of murine cytomegalovirus.
Smee DF; Barnett BB; Sidwell RW; Reist EJ; Holy A
Antiviral Res; 1995 Jan; 26(1):1-9. PubMed ID: 7741517
[TBL] [Abstract][Full Text] [Related]
10. Treatment of murine cytomegalovirus infections in severe combined immunodeficient mice with ganciclovir, (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine, interferon, and bropirimine.
Smee DF; Morris JL; Leonhardt JA; Mead JR; Holy A; Sidwell RW
Antimicrob Agents Chemother; 1992 Sep; 36(9):1837-42. PubMed ID: 1329629
[TBL] [Abstract][Full Text] [Related]
11. Phosphonylmethoxyalkyl purine and pyrimidine derivatives for treatment of opportunistic cytomegalovirus and herpes simplex virus infections in murine AIDS.
De Castro LM; Kern ER; De Clercq E; Ghaffar A; Mayer EP; Vogt PE; Gangemi JD
Antiviral Res; 1991 Jul; 16(1):101-14. PubMed ID: 1663726
[TBL] [Abstract][Full Text] [Related]
12. Antiviral activity of anti-cytomegalovirus agents (HPMPC, HPMPA) assessed by a flow cytometric method and DNA hybridization technique.
Snoeck R; Schols D; Andrei G; Neyts J; De Clercq E
Antiviral Res; 1991 Jul; 16(1):1-9. PubMed ID: 1663725
[TBL] [Abstract][Full Text] [Related]
13. Comparative inhibitory effects of nucleoside analogues on different clinical isolates of human cytomegalovirus in vitro.
Shigeta S; Konno K; Baba M; Yokota T; De Clercq E
J Infect Dis; 1991 Feb; 163(2):270-5. PubMed ID: 1846389
[TBL] [Abstract][Full Text] [Related]
14. Rat cytomegalovirus-induced pneumonitis after allogeneic bone marrow transplantation: effective treatment with (S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine.
Stals FS; Zeytinoglu A; Havenith M; de Clercq E; Bruggeman CA
Antimicrob Agents Chemother; 1993 Feb; 37(2):218-23. PubMed ID: 8383939
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)-cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)-guanine in the treatment of intracerebral murine cytomegalovirus infections in immunocompetent and immunodeficient mice.
Neyts J; Sobis H; Snoeck R; Vandeputte M; De Clercq E
Eur J Clin Microbiol Infect Dis; 1993 Apr; 12(4):269-79. PubMed ID: 8390357
[TBL] [Abstract][Full Text] [Related]
16. Selective inhibition of human papillomavirus-induced cell proliferation by (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine.
Johnson JA; Gangemi JD
Antimicrob Agents Chemother; 1999 May; 43(5):1198-205. PubMed ID: 10223936
[TBL] [Abstract][Full Text] [Related]
17. Antiproliferative effects of acyclic nucleoside phosphonates on human papillomavirus (HPV)-harboring cell lines compared with HPV-negative cell lines.
Andrei G; Snoeck R; Piette J; Delvenne P; De Clercq E
Oncol Res; 1998; 10(10):523-31. PubMed ID: 10338155
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of potent inhibitors of human immunodeficiency virus and cytomegalovirus on the growth of human granulocyte-macrophage progenitor cells in vitro.
Snoeck R; Lagneaux L; Delforge A; Bron D; Van der Auwera P; Stryckmans P; Balzarini J; De Clercq E
Eur J Clin Microbiol Infect Dis; 1990 Aug; 9(8):615-9. PubMed ID: 2170136
[TBL] [Abstract][Full Text] [Related]
19. (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) inhibits HIV-1 replication in epithelial cells, but not T-lymphocytes.
Srinivas RV; Connely M; Fridland A
Antiviral Res; 1997 Jun; 35(1):23-7. PubMed ID: 9224958
[TBL] [Abstract][Full Text] [Related]
20. New inhibitors of cytomegalovirus replication: in vitro evaluation, mechanism of action, and in vivo activity.
Neyts J; De Clercq E
Verh K Acad Geneeskd Belg; 1994; 56(6):561-92. PubMed ID: 7892749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]